Tenax Therapeutics, Inc. · NASDAQ:TENX
ADAR1 Capital Management, LLC bought 922,849 Tenax Therapeutics, Inc. shares (Form 4)
Traded Oct 19 to Oct 21, 2026 · Filed Oct 21, 2026
From Oct 19 to Oct 21, 2026, ADAR1 Capital Management, LLC (10% owner) bought 922,849 Tenax Therapeutics, Inc. shares at an average US$1.59 for US$1.46M, leaving 7,447,000 shares. Filed Oct 21, 2026 (Form 4).
- Bought
- 922,849 shares
- Price
- US$1.59 average (US$1.51 to US$1.66)
- Value
- US$1.46M
- Holding after
- 7,447,000 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Common Stock | Buy | 336,528 | US$1.51 | 6,860,679 | Indirect |
| Oct 20, 2026 | Common Stock | Buy | 254,342 | US$1.60 | 7,115,021 | Indirect |
| Oct 21, 2026 | Common Stock | Buy | 331,979 | US$1.66 | 7,447,000 | Indirect |
Source
Download original · View original at SEC
Related
- Tenax Therapeutics, Inc.
- ADAR1 Capital Management, LLC
- Tenax Therapeutics, Inc. shareholders
- Form 4 · ADAR1 Capital Management, LLC · Sep 8, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026
- Form 4 · Giordano Christopher Thomas · Sep 15, 2026